ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Paris, Île-de-France

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Ulcer
Kidney Diseases

Diabetes trials near Paris, Île-de-France, FRA:

Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes (DF-IL2-REP)

Type 1 diabetes (T1D) is caused by the destruction of insulin-producing cells by effector T cells (Teffs), due to a deficiency of regulatory...

Enrolling
Type 1 Diabetes
Drug: ILT101
Drug: Cyclosporin

Phase 2

Assistance Publique - Hôpitaux de Paris

Paris, France

100 mg once per day on a composite end-point of ischemic events in diabetic patients, or in patients with a known risk factor for non-optima...

Active, not recruiting
Diabetes Mellitus
Coronary Artery Disease
Drug: Novel strategy Aspirin
Drug: Conventional strategy Aspirin

Phase 4

Assistance Publique - Hôpitaux de Paris

Paris, France

Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled with insulin therapy. The purpose of ...

Enrolling
Type 2 Diabetes
Device: Duodenal Mucosal Resurfacing (Sham)
Device: Duodenal Mucosal Resurfacing (DMR)
Fractyl Health

Paris, France and 64 other locations

Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia due to deficiency in either insulin secretion, insulin acti...

Enrolling
Diabetes Mellitus
Dietetic Rules
Other: Week end
Other: SPA Treatment with therapeutic education and physical activity
Association Francaise pour la Recherche Thermale

Corbeil-Essonnes, France and 8 other locations

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting
Diabetes
Coronary Artery Disease
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Concept Medical
Concept Medical

Paris, France and 89 other locations

Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...

Enrolling
Type 1 Diabetes
Device: Subject's Current Diabetes Therapy
Device: 670G and 770G Insulin Pump
Medtronic
Medtronic

Paris, France and 37 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Bondy, France and 78 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Paris, Île-de-France, France and 651 other locations

The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes...

Enrolling
Diabetes Mellitus, Type 1
Biological: TCD601
Other: Placebo

Phase 2

ITBMed

Paris, France and 37 other locations

This study is a randomized, controlled trial to evaluate the efficacy and safety of the Omnipod® 5 System with the FreeStyle Libre 2 continuous gluco...

Active, not recruiting
Diabetes Mellitus, Type 1
Device: Omnipod 5 System
Insulet

Paris, France and 18 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems